cephalosporin c has been researched along with 1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate monohydrate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furubou, S; Minami, S; Morita, T; Narita, H; Takahata, M; Todo, Y; Watanabe, Y; Yamada, H | 1 |
1 other study(ies) available for cephalosporin c and 1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate monohydrate
| Article | Year |
|---|---|
Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.
Topics: Animals; Anti-Infective Agents; Brain; Ceftriaxone; Cephalosporins; Fluoroquinolones; Indoles; Injections, Intravenous; Isoindoles; Male; Meningitis, Pneumococcal; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae | 2002 |